UIC Nursing ranked No. 7 among U.S. nursing schools for NIH funding

Research rewards: UIC Nursing's ranking went from No. 11 in 2023 to No. 7 in 2024

The UIC College of Nursing was ranked No. 7 among U.S. nursing schools for National Institutes of Health funding in 2024 with $10.1 million, a mark of the college’s research strength.

That’s a climb of four spots from 2023 when the college brought in $7.7 million in NIH funding.

UIC Nursing was No. 1 for NIH funding in the Midwest in 2024 and topped $10 million in funding since the Blue Ridge Institute for Medical Research started reporting rankings in 2006.

“The level of NIH funding we receive is a source of pride because it reflects the quality and vibrancy of nursing research at our college,” says Dean Eileen Collins, PhD, RN, FAAN, ATSF. “Our researchers are using NIH funding to improve the health of individuals with diabetes, sickle cell disease, and kidney disease and to help prevent potentially devastating diseases like dementia and HIV. It’s critical work and so gratifying to know we’re continuing to be leaders in research.”

The other schools in the top 10 are:

  1. Columbia University Health Sciences
  2. University of Pennsylvania
  3. Emory University
  4. Florida State University
  5. University of California San Francisco
  6. Johns Hopkins University
  7. University of Illinois Chicago
  8. Arizona State University – Tempe campus
  9. University of Washington Seattle
  10. University of Pittsburgh

Among UIC Nursing’s NIH grants, Ardith Doorenbos, PhD, RN, FAAN, Harriet H. Werley Endowed Chair for Nursing Research, is investigating strategies to relieve chronic sickle cell disease pain. Mark Lockwood, PhD, RN, associate professor, is studying the mechanism underlying pain in kidney transplantation. Shannon Halloway, PhD, RN, FAAN, FAHA, associate professor, is exploring how changes in lifestyle behaviors can improve cognition. Natasha Crooks, PhD, RN, is evaluating a program to involve male caregivers in preventing HIV among Black girls. Pamela Martyn-Nemeth is studying how sleep and circadian rhythms affect glucose control in people with Type 1 diabetes.

See: All College News